Brace Relief Gel
NDC Package 60306-115-05

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings

Package Information

Brace Relief (benzocaine) gel is apply to irritated areas as needed See package insert for instructions, warnings & cautions. This formulation utilizes a gel delivery system. Marketed by Infalab,inc, this product is identified by NDC 60306-115 and is authorized under FDA application M004.

Identification & Billing

NDC Package Code
60306-115-05
Package Description
.3 mL in 1 TUBE
Product Code
11-Digit Billing Format
60306011505
RxNorm Crosswalk

Clinical Specifications

Proprietary Name
Brace Relief
Non-Proprietary Name
Benzocaine
Substance Name
Benzocaine
Dosage Form
Gel - A semisolid3 dosage form that contains a gelling agent to provide stiffness to a solution or a colloidal dispersion.4 A gel may contain suspended particles.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Usage Information
Apply to irritated areas as needed See package insert for instructions, warnings & cautions.

Regulatory & Marketing

Labeler Name
Infalab,inc
Product Type
Human Otc Drug
FDA Application #
M004
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
01-03-2005
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 60306-115-05 identifies a specific commercial package of .3 ml in 1 tube of Brace Relief, a human over the counter drug labeled by Infalab,inc. This gel is formulated for oral use and contains benzocaine as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Infalab,inc on January 03, 2005. The current certification is valid through December 31, 2027.

How is this Infalab,inc product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 60306011505. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
60306-115-05
11-Digit CMS (5-4-2)
60306-0115-05

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.